The Health Policy Exchange
MAY 7, 2013
To supporters of the Affordable Care Act, legislative expansion of the Medicaid program is a welcome financial and health care bonanza for states and uninsured patients.
The Direct Doctors Difference
AUGUST 18, 2021
Looking back to 2014, when we began, there were less than 100. The strength also comes from a group of physicians who want something more and something better - improved work-life balance, return of joy to practicing medicine, and a renewal of the pure physician-patient relationship where the doctor knows his or her patient well.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MAY 7, 2025
Two recent cases from the Fifth and Seventh Circuits, however, support the legality of these arrangements in the absence of the government proving certain circumstances. Physicians had ultimate control and exercised independent judgment over their patients healthcare decisions. Mallory , 988 F.3d 3d 730 (4th Cir. Medicare or Medicaid).
FDA Law Blog
JANUARY 18, 2022
In October 2014, FDA held a public workshop titled “Additive Manufacturing of Medical Devices: An Interactive Discussion on the Technical Considerations of 3D Printing.” Specifically, that it allows for fast production of “patient-matched devices” (i.e., products intended for medical purposes).
BMJ
JULY 17, 2020
Many Chinese expressed their disapproval of the many untrusted sources of information online while demonstrating a high level of trust towards the central government. How to reduce the negative psychological impact MRSA isolation on patients. 2014 (28 August). National involvement is also needed to facilitate these efforts.
FDA Law Blog
JANUARY 12, 2025
Since that time, it was formalized in FDA regulations (21 CFR 314 Subpart H) in 1992, codified in the Food, Drug, & Cosmetic Act by FDAMA (21 USC 356(c)) in 1997, revised by FDASIA in 2012, and described in guidance, most importantly, in the 2014 Expedited Programs for Serious Conditions Drugs and Biologics (2014 Guidance).
FDA Law Blog
SEPTEMBER 29, 2021
Manufacturers may choose not to participate in this program, but the federal government will not reimburse for their outpatient drugs under Medicaid or Medicare Part B if they do not. A 2018 report by the Government Accountability Office (“GAO”) found similar issues, as well as contract pharmacy noncompliance and poor federal oversight.
Expert insights. Personalized for you.
130 
Let's personalize your content